Literature DB >> 20889194

The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.

John J Lee1, Haifa H Jabara, Lilit Garibyan, Ingrid Rauter, Tatyana Sannikova, Stacey R Dillon, Richard Bram, Raif S Geha.   

Abstract

BACKGROUND: TNFRSF13B, which encodes transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), is mutated in 10% of patients with common variable immunodeficiency. One of the 2 most common TACI mutations in common variable immunodeficiency, C104R, abolishes ligand binding and is found predominantly in the heterozygous state. The murine TACI mutant C76R is the equivalent of the human TACI mutant C104R.
OBJECTIVE: We sought to define the consequence of the C76R mutation on TACI function in mice that express both wild-type TACI and the murine C76R mutant.
METHODS: Transgenic mice that express murine TACI C76R, the counterpart of human TACI C104R, on the TACI(+/-) B6/129 background (C76R/TACI(+/-) mice) were constructed. Serum immunoglobulins and antibody responses to the type II T-independent antigen trinitrophenylated (TNP)-Ficoll were determined by means of ELISA. B-cell proliferation in response to a proliferation-inducing ligand was determined based on tritiated thymidine incorporation into DNA. IgG1 secretion by B cells in response to a proliferation-inducing ligand plus IL-4 was determined by means of ELISA.
RESULTS: C76R/TACI(+/-) mice had significantly impaired antibody responses to the type II T-independent antigen TNP-Ficoll compared with TACI(+/+) B6/129 control animals, and their B cells were impaired in their capacity to proliferate and secrete IgG1 in response to TACI ligation. Unexpectedly, TACI(+/-) mice had similarly impaired B-cell function as C76R/TACI(+/-) littermates. Impaired TACI function caused by haploinsufficiency was confirmed in TACI(+/-) mice on the C57BL/6 background.
CONCLUSION: These results suggest that the human TACI mutant C104R might impair TACI function in heterozygotes through haploinsufficiency.
Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889194      PMCID: PMC3122265          DOI: 10.1016/j.jaci.2010.08.017

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  27 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

Review 2.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.

Authors:  Haifa Jabara; Dhafer Laouini; Erdyni Tsitsikov; Emiko Mizoguchi; Atul Bhan; Emanuela Castigli; Fatma Dedeoglu; Vadim Pivniouk; Scott Brodeur; Raif Geha
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

Review 4.  Common variable immunodeficiency: a review.

Authors:  M Di Renzo; A L Pasqui; A Auteri
Journal:  Clin Exp Med       Date:  2004-04       Impact factor: 3.984

5.  NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily.

Authors:  G U von Bülow; R J Bram
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

6.  TACI is mutant in common variable immunodeficiency and IgA deficiency.

Authors:  Emanuela Castigli; Stephen A Wilson; Lilit Garibyan; Rima Rachid; Francisco Bonilla; Lynda Schneider; Raif S Geha
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

7.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.

Authors:  J M Spergel; E Mizoguchi; J P Brewer; T R Martin; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

8.  Activation and accumulation of B cells in TACI-deficient mice.

Authors:  M Yan; H Wang; B Chan; M Roose-Girma; S Erickson; T Baker; D Tumas; I S Grewal; V M Dixit
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

9.  TACI and BAFF-R mediate isotype switching in B cells.

Authors:  Emanuela Castigli; Stephen A Wilson; Sumi Scott; Fatma Dedeoglu; Shengli Xu; Kong-Peng Lam; Richard J Bram; Haifa Jabara; Raif S Geha
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

10.  Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes.

Authors:  A C Shaw; W Swat; R Ferrini; L Davidson; F W Alt
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  23 in total

Review 1.  Advances in basic and clinical immunology in 2010.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

2.  Common variable immunodeficiency: two mutations are better than one.

Authors:  Antonio La Cava
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

Review 3.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

4.  Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome.

Authors:  Javier Chinen; Monica Martinez-Gallo; Wenli Gu; Montserrat Cols; Andrea Cerutti; Lin Radigan; Li Zhang; Lorraine Potocki; Marjorie Withers; James R Lupski; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2011-04-22       Impact factor: 10.793

5.  Differential induction of plasma cells by isoforms of human TACI.

Authors:  Yolanda Garcia-Carmona; Montserrat Cols; Adrian T Ting; Lin Radigan; Frank J Yuk; Li Zhang; Andrea Cerutti; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2015-01-28       Impact factor: 22.113

6.  Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).

Authors:  Wikke Koopmans; See-Tarn Woon; Anna E S Brooks; P Rod Dunbar; Peter Browett; Rohan Ameratunga
Journal:  J Clin Immunol       Date:  2012-09-15       Impact factor: 8.317

7.  TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow.

Authors:  Shoichiro Tsuji; Catarina Cortesão; Richard J Bram; Jeffrey L Platt; Marilia Cascalho
Journal:  Blood       Date:  2011-10-07       Impact factor: 22.113

8.  Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.

Authors:  Haifa H Jabara; John J Lee; Erin Janssen; Sumana Ullas; Kyriaki Liadaki; Lilit Garibyan; Halli Benson; Tatyana Sannikova; Richard Bram; Lennart Hammarstrom; Anthony C Cruz; Richard Siegel; John Manis; Richard Malley; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2016-09-05       Impact factor: 10.793

9.  CVID-associated TACI mutations affect autoreactive B cell selection and activation.

Authors:  Neil Romberg; Nicolas Chamberlain; David Saadoun; Maurizio Gentile; Tuure Kinnunen; Yen Shing Ng; Manmeet Virdee; Laurence Menard; Tineke Cantaert; Henner Morbach; Rima Rachid; Natalia Martinez-Pomar; Nuria Matamoros; Raif Geha; Bodo Grimbacher; Andrea Cerutti; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

10.  TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.

Authors:  Neil Romberg; Manmeet Virdee; Nicolas Chamberlain; Tyler Oe; Jean-Nicolas Schickel; Tiffany Perkins; Tineke Cantaert; Rima Rachid; Sally Rosengren; Regina Palazzo; Raif Geha; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2015-06-19       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.